Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2601 ARTíCULOS , VIENDO DEL 91 AL 105

PUBMED

Testosterone as the missing link between pesticides, Alzheimer disease, and Parkinson disease.

Martins R, Carruthers M.

JAMA Neurol. 2014 Sep;71(9):1189-90. doi: 10.1001/jamaneurol.2014.795. No abstract available.

0

0

0

PUBMED

Magnetic resonance spectroscopy: an in vivo molecular imaging biomarker for Parkinson's disease?

Ciurleo R, Di Lorenzo G, Bramanti P, Marino S.

Biomed Res Int. 2014;2014:519816. doi: 10.1155/2014/519816. Review.

0

0

0

PUBMED

Animal models of Parkinson's disease: a gateway to therapeutics?

Le W, Sayana P, Jankovic J.

Neurotherapeutics. 2014 Jan;11(1):92-110. doi: 10.1007/s13311-013-0234-1. Review.

0

0

0

PUBMED

Continuous positive airway pressure improves sleep and daytime sleepiness in patients with Parkinson disease and sleep apnea.

Neikrug AB, Liu L, Avanzino JA, Maglione JE, Natarajan L, Bradley L, Maugeri A, Corey-Bloom J, Palmer BW, Loredo JS, Ancoli-Israel S.

Sleep. 2014 Jan 1;37(1):177-85. doi: 10.5665/sleep.3332.

0

0

0

PUBMED

[The significance of oxidized DJ-1 protein (oxDJ-1) as a biomarker for Parkinson's disease].

Ogawa I, Saito Y, Saigoh K, Hosoi Y, Mitsui Y, Noguchi N, Kusunoki S.

Brain Nerve. 2014 Apr;66(4):471-7. Japanese.

0

0

0

PUBMED

Structural brain abnormalities in patients with Parkinson's disease with visual hallucinations: a comparative voxel-based analysis.

Gama RL, Bruin VM, Távora DG, Duran FL, Bittencourt L, Tufik S.

Brain Cogn. 2014 Jun;87:97-103. doi: 10.1016/j.bandc.2014.03.011.

0

0

0

PUBMED

Parkinson-related LRRK2 mutation R1441C/G/H impairs PKA phosphorylation of LRRK2 and disrupts its interaction with 14-3-3.

Muda K, Bertinetti D, Gesellchen F, Hermann JS, von Zweydorf F, Geerlof A, Jacob A, Ueffing M, Gloeckner CJ, Herberg FW.

Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):E34-43. doi: 10.1073/pnas.1312701111.

0

0

0

PUBMED

NAC1, A POZ/BTB protein interacts with Parkin and may contribute to Parkinson's disease.

Korutla L, Furlong HA 4th, Mackler SA.

Neuroscience. 2014 Jan 17;257:86-95. doi: 10.1016/j.neuroscience.2013.11.001.

0

0

0

PUBMED

Origins and suppression of oscillations in a computational model of Parkinson's disease.

Holt AB, Netoff TI.

J Comput Neurosci. 2014 Dec;37(3):505-21. doi: 10.1007/s10827-014-0523-7.

0

0

0

PUBMED

Current Challenges Towards the Development of a Blood Test for Parkinson's Disease.

Santiago JA, Potashkin JA.

Diagnostics (Basel). 2014 Oct 22;4(4):153-64. doi: 10.3390/diagnostics4040153. Review.

0

0

0

PUBMED

Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model.

Chotibut T, Davis RW, Arnold JC, Frenchek Z, Gurwara S, Bondada V, Geddes JW, Salvatore MF.

Mol Neurobiol. 2014 Jun;49(3):1282-92. doi: 10.1007/s12035-013-8598-0.

0

0

0

PUBMED

Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease.

Joers V, Emborg ME.

Am J Nucl Med Mol Imaging. 2014 Mar 20;4(2):125-59. Review.

0

0

0

PUBMED

A survey of Parkinson's disease patients: most bothersome symptoms and coping preferences.

Uebelacker LA, Epstein-Lubow G, Lewis T, Broughton MK, Friedman JH.

J Parkinsons Dis. 2014;4(4):717-23. doi: 10.3233/JPD-140446.

0

0

0

PUBMED

(6aR)-11-amino-N-propyl-noraporphine, a new dopamine D2 and serotonin 5-HT1A dual agonist, elicits potent antiparkinsonian action and attenuates levodopa-induced dyskinesia in a 6-OHDA-lesioned rat model of Parkinson's disease.

Zhao R, Lu W, Fang X, Guo L, Yang Z, Ye N, Zhao J, Liu Z, Jia J, Zheng L, Zhao B, Zhang A, Zhen X.

Pharmacol Biochem Behav. 2014 Sep;124:204-10. doi: 10.1016/j.pbb.2014.06.011.

0

0

0

PUBMED

Conditional expression of Parkinson's disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration.

Tsika E, Kannan M, Foo CS, Dikeman D, Glauser L, Gellhaar S, Galter D, Knott GW, Dawson TM, Dawson VL, Moore DJ.

Neurobiol Dis. 2014 Nov;71:345-58. doi: 10.1016/j.nbd.2014.08.027.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy